Merck & Company, Inc. · NYSE:MRK
DeLuca Richard R. sold 58,185 Merck & Company, Inc. shares (Form 4)
Traded Nov 12, 2026 · Filed Nov 16, 2026
On Nov 12, 2026, DeLuca Richard R. (EVP&Pres, Merck Animal Heallth) sold 58,185 Merck & Company, Inc. shares at US$148.01 for US$8.61M, leaving 112,955 shares. Filed Nov 16, 2026 (Form 4).
- Sold
- 58,185 shares
- Price
- US$148.01
- Value
- US$8.61M
- Holding after
- 112,955 shares
- Trading plan
- No
- Role
- EVP&Pres, Merck Animal Heallth
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 12, 2026 | Common Stock | Option exercise | 58,185 | US$77.62 | 171,140 | Direct |
| Nov 12, 2026 | Common Stock | Sale | 58,185 | US$148.01 | 112,955 | Direct |
Source
Download original · View original at SEC
Related
- Merck & Company, Inc.
- DeLuca Richard R.
- Merck & Company, Inc. shareholders
- Form 4 · DeLuca Richard R. · Aug 12, 2026
- Form 4 · DeLuca Richard R. · Aug 10, 2026
- Form 4 · DeLuca Richard R. · May 1, 2026
- Form 4 · Guindo Chirfi · Aug 13, 2026
- Form 4 · Zachary Jennifer · Aug 13, 2026
- Form 4 · Guindo Chirfi · Aug 7, 2026
- Form 4 · Maraldo David R. · Aug 7, 2026
- Form 4 · Williams David Michael · Aug 7, 2026